MEDICAL COLLEGE OF VIRGINIA EPILEPSY RESEARCH CENTER

弗吉尼亚医学院癫痫研究中心

基本信息

  • 批准号:
    6039554
  • 负责人:
  • 金额:
    $ 98.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-01-01 至 2005-01-31
  • 项目状态:
    已结题

项目摘要

Status epilepticus (SE) is a major medical emergency, causing more than 35,000 deaths each year in the United States. The four research projects of this Epilepsy Research Center (ERC) at the Medical College of Virginia of Virginia Commonwealth University are focused on the CENTRAL THEME of studying SE. These projects compliment each other and the interaction of multi-disciplined investigators around a common theme greatly enhances the development of new insights and research productivity. The four projects will test specific hypotheses developed to investigate clinical aspects and basic mechanisms of SE are: SE: A Clinical and Epidemiological Study; Pathophysiology and Mortality of SE; Genetic Preponderance of SE in Twin Kindreds; and SE Duration- Dependent Modulation of GABAA Receptor Function. The clinical projects will offer important new insights into the epidemiology of SE in the elderly, the neonatal period, the young child, and different ethnic groups. This research will also produce a SE Outcome Scale for identifying high risk patients that can be used for clinical assessment and future therapeutic interventions. The intensive cardiac and central nervous system (CNS) physiological monitoring will test preliminary evidence that persistent CNS excitability predicts HIGH RISK patients for cardiac abnormalities that may ultimately lead to death in SE. In addition, this research effort has identified non-convulsive SE as a major cause of morbidity and mortality and has developed a prospective data base to evaluate this under recognized form of SE in the comatose patient. Utilizing one of the largest twin registries in the world, studies are proposed that provide the first direct evidence that the development of SE in man is controlled in part by a genetic predisposition. Animal models of SE demonstrate that there is a modulation of the GABAA receptor function that underlies the development of SE intractability and resistance to treatment. Studies indicate that alterations in the gamma amino butyric acid (GABA) receptor function play a major role in the pathogenesis of SE. The accomplishments of this research program are enhanced by the collaboration between committed investigators and research projects. The results from this study will ultimately develop new strategies to offer insights into the pathophysiology of SE and improve the diagnosis and treatment of this severe neurological condition.
癫痫持续状态(SE)是一种主要的医疗紧急情况,在美国每年造成超过35,000人死亡。弗吉尼亚联邦大学弗吉尼亚医学院癫痫研究中心(ERC)的四个研究项目集中在研究SE的中心主题上。这些项目相互补充,多学科研究人员围绕一个共同主题的互动大大提高了新见解和研究生产力的发展。这四个项目将测试为研究SE的临床方面和基本机制而开发的特定假设:SE:临床和流行病学研究; SE的病理生理学和死亡率; SE在双胞胎运动中的遗传优势;以及SE持续时间依赖性GABAA受体功能调节。这些临床项目将为老年人、新生儿、幼儿和不同种族群体的SE流行病学提供重要的新见解。这项研究还将产生一个SE结局量表,用于识别高风险患者,可用于临床评估和未来的治疗干预。密集的心脏和中枢神经系统(CNS)生理监测将测试初步证据,即持续的CNS兴奋性预测高风险患者的心脏异常,最终可能导致SE患者死亡。此外,这项研究工作已确定非惊厥性SE是发病率和死亡率的主要原因,并开发了一个前瞻性数据库,以评估在昏迷患者中公认的SE形式。利用世界上最大的双胞胎登记处之一,提出了研究,提供了第一个直接证据,表明SE的发展在一定程度上是由遗传易感性控制的人。 SE的动物模型表明,存在GABAA受体功能的调节,其是SE顽固性和治疗抗性发展的基础。研究表明,γ-氨基丁酸(GABA)受体功能的改变在SE的发病机制中起着重要作用。该研究计划的成就通过致力于研究人员和研究项目之间的合作得到加强。这项研究的结果将最终开发新的策略,以深入了解SE的病理生理学,并改善这种严重神经系统疾病的诊断和治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT John DELORENZO其他文献

ROBERT John DELORENZO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT John DELORENZO', 18)}}的其他基金

Novel Counteract Agents To Reduce Mortality And Morbidity Following Organophosphate Status Epilepticus
新型对抗剂可降低有机磷癫痫持续状态后的死亡率和发病率
  • 批准号:
    9349995
  • 财政年份:
    2017
  • 资助金额:
    $ 98.2万
  • 项目类别:
HYPOTHERMIA REDUCES MORTALITY AND MORBIDITY FROM STATUS EPILEPTICUS
低温可降低癫痫持续状态的死亡率和发病率
  • 批准号:
    9084757
  • 财政年份:
    2015
  • 资助金额:
    $ 98.2万
  • 项目类别:
HYPOTHERMIA PROTECTS AGAINST ORGANOPHOSPHATE TOXICITY
低温可防止有机磷酸盐中毒
  • 批准号:
    8337698
  • 财政年份:
    2011
  • 资助金额:
    $ 98.2万
  • 项目类别:
HYPOTHERMIA PROTECTS AGAINST ORGANOPHOSPHATE TOXICITY
低温可防止有机磷酸盐中毒
  • 批准号:
    8215143
  • 财政年份:
    2011
  • 资助金额:
    $ 98.2万
  • 项目类别:
MECHANISM OF CANNABINOID ANTI-CONVULSANT EFFECTS
大麻素抗惊厥作用机制
  • 批准号:
    7318589
  • 财政年份:
    2007
  • 资助金额:
    $ 98.2万
  • 项目类别:
STATUS EPILEPTICUS REORGANIZES CANNABINOID RECEPTORS
癫痫持续状态重组大麻素受体
  • 批准号:
    7994399
  • 财政年份:
    2007
  • 资助金额:
    $ 98.2万
  • 项目类别:
STATUS EPILEPTICUS REORGANIZES CANNABINOID RECEPTORS
癫痫持续状态重组大麻素受体
  • 批准号:
    7342830
  • 财政年份:
    2007
  • 资助金额:
    $ 98.2万
  • 项目类别:
STATUS EPILEPTICUS REORGANIZES CANNABINOID RECEPTORS
癫痫持续状态重组大麻素受体
  • 批准号:
    7540372
  • 财政年份:
    2007
  • 资助金额:
    $ 98.2万
  • 项目类别:
STATUS EPILEPTICUS REORGANIZES CANNABINOID RECEPTORS
癫痫持续状态重组大麻素受体
  • 批准号:
    7196351
  • 财政年份:
    2007
  • 资助金额:
    $ 98.2万
  • 项目类别:
PATHOPHYSIOLOGY AND MORTALITY OF STATUS EPILEPTICUS
癫痫持续状态的病理生理学和死亡率
  • 批准号:
    7148603
  • 财政年份:
    2006
  • 资助金额:
    $ 98.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了